Clinical Trial

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

Study acronym: REGATA
Recruiting
View on ClinicalTrials.gov →
Summary
The investigators will collect biosamples of patient blood and tumour tissue for further immunological analysis of blood cell subpopulations, immunosupressive factors concentration, HLA expression an lymphocytes and tumour tissue, and and cancer testis antigenes expression on tumour cells, as well as clinical data on patient's stage, therapy, response and demographics. Possible prognostic and predictive dynamic biomarkers will be discovered for individualisation of treatment strategies
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-09-13.
Trial Details
NCT Number NCT05539677
Lead Sponsor N.N. Petrov National Medical Research Center of Oncology
Conditions Malignant Solid Tumors, Primary Brain Tumor, Melanoma, Soft Tissue Sarcoma, Colorectal Cancer, Kidney Cancer, Prostate Cancer
Enrollment 1,000 participants
Start Date 1998-09
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2024-05-06